Affymetrix's Q4 Sales Surge 13 Percent

The firm's late-year surge in sales led to 13 percent revenue growth for Q4, easily beating market estimates. Its shares soared in early Thursday trading.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories